These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 5987888)

  • 1. [Comparison of metabolite patterns in the brain, other organs and urine by the example of thymoleptics].
    Bickel MH; Weder HJ; Baggiolini M
    Helv Physiol Pharmacol Acta; 1966 Nov; 68():C77-8. PubMed ID: 5987888
    [No Abstract]   [Full Text] [Related]  

  • 2. [Absorption and organ distribution of the new antidepressant azaphen].
    Siniukhin VN
    Farmakol Toksikol; 1973; 26(4):409-11. PubMed ID: 4789881
    [No Abstract]   [Full Text] [Related]  

  • 3. On the distribution and metabolism of neuroleptic drugs. 3. Pharmacokinetics of trifluperidol.
    Lewi PJ; Heykants JJ; Janssen PA
    Arzneimittelforschung; 1970 Nov; 20(11):1701-5. PubMed ID: 5536974
    [No Abstract]   [Full Text] [Related]  

  • 4. Histamine receptors in the brain: characterization by binding studies and biochemical effects.
    Schwartz JC; Barbin G; Duchemin AM; Garbarg M; Palacios JM; Quach TT; Rose C
    Adv Biochem Psychopharmacol; 1980; 21():169-82. PubMed ID: 6103644
    [No Abstract]   [Full Text] [Related]  

  • 5. [Studies on the resorption and metabolism of the antidepressant 9,9-dimethyl-10-(3-dimethyl-aminopropyl)-acridan-hydrogen tartrate].
    Schatz F; Jahn U; Adrian RW; Molnar I
    Arzneimittelforschung; 1968 Jul; 18(7):862-71. PubMed ID: 5755833
    [No Abstract]   [Full Text] [Related]  

  • 6. Specific binding of radiolabelled antidepressants to brain astroglial cells.
    Whitaker PM; Warsh JJ
    Adv Biochem Psychopharmacol; 1983; 37():477-85. PubMed ID: 6637603
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacokinetic study of trimethadione and its metabolite in blood, liver and brain by microdialysis in conscious, unrestrained rats.
    Kurata N; Inagaki M; Iwase M; Nishimura Y; Kiuchi Y; Yamazaki Y; Kobayashi S; Oguchi K; Uchida E; Yasuhara H
    Res Commun Mol Pathol Pharmacol; 1995 Jul; 89(1):45-56. PubMed ID: 7582861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of typical and atypical antidepressant recognition sites in rat brain.
    Brunello N; Chuang DM; Costa E
    Adv Biochem Psychopharmacol; 1982; 31():179-84. PubMed ID: 6211062
    [No Abstract]   [Full Text] [Related]  

  • 9. [Metabolism of the antidepressant azaphene in rats].
    Gortinskaia TV; Siniukhin VN; Ostroumova HG; Rozynov BV; Nyrkova VG
    Farmakol Toksikol; 1973; 36(5):673-7. PubMed ID: 4802265
    [No Abstract]   [Full Text] [Related]  

  • 10. [How large is the tocopherol accumulation capacity of organs? Long term trials with various high oral alpha-tocopherol doses administered to rats and guinea pigs].
    Elmadfa I; Walter A
    Int J Vitam Nutr Res; 1981; 51(3):284-92. PubMed ID: 7319728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Enterohepatic cycle of fenpentadiol in rats: calculation of pharmacokinetic parameters].
    Dormard Y; Levron JC
    Eur J Toxicol; 1972; 5(1):43-8. PubMed ID: 4647422
    [No Abstract]   [Full Text] [Related]  

  • 12. Relationship between bupropion disposition and dopamine uptake inhibition in rats and mice.
    Butz RF; Welch RM; Findlay JW
    J Pharmacol Exp Ther; 1982 Jun; 221(3):676-85. PubMed ID: 6806465
    [No Abstract]   [Full Text] [Related]  

  • 13. Fluvoxamine: metabolic fate in animals.
    Ruijten HM; de Bree H; Borst AJ; de Lange N; Scherpenisse PM; Vincent WR; Post LC
    Drug Metab Dispos; 1984; 12(1):82-92. PubMed ID: 6141918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacokinetics of antidepressive agents].
    Tillement JP
    Therapie; 1973; 28(2):249-68. PubMed ID: 4766358
    [No Abstract]   [Full Text] [Related]  

  • 15. Metabolism of some phenylethylamines and their beta-hydroxylated analogs in brain.
    Breese GR; Chase TN; Kopin IJ
    J Pharmacol Exp Ther; 1969 Jan; 165(1):9-13. PubMed ID: 5782838
    [No Abstract]   [Full Text] [Related]  

  • 16. Response of the histamine h2-receptor in brain to antidepressant drugs.
    Maayani S; Hough LB; Weinstein H; Green JP
    Adv Biochem Psychopharmacol; 1982; 31():133-47. PubMed ID: 6123221
    [No Abstract]   [Full Text] [Related]  

  • 17. Chiral resolution and binding study of 1,3,4,14b-tetrahydro-2,10-dimethyl-2H,10H-pyrazino[2,1-d]pyrrolo[1,2-b] [1,2,5]benzotriazepine (10-methyl-10-azaaptazepine) and 2-methyl-1,3,4,14b-tetrahydro-2H-pyrazino[2,1-d]pyrrolo[1,2-b] [1,2,5]benzothiadiazepine 10,10-dioxide (tiaaptazepine).
    De Martino G; La Regina G; La Torre F; Cirilli R; Mereghetti I; Cagnotto A; Artico M; Silvestri R
    Farmaco; 2005; 60(11-12):931-7. PubMed ID: 16223499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition of valpromide, valproic acid, and valnoctamide in the brain, liver, plasma, and urine of rats.
    Blotnik S; Bergman F; Bialer M
    Drug Metab Dispos; 1996 May; 24(5):560-4. PubMed ID: 8723737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anxiolytic-like and antidepressant-like activities of MCL0129 (1-[(S)-2-(4-fluorophenyl)-2-(4-isopropylpiperadin-1-yl)ethyl]-4-[4-(2-methoxynaphthalen-1-yl)butyl]piperazine), a novel and potent nonpeptide antagonist of the melanocortin-4 receptor.
    Chaki S; Hirota S; Funakoshi T; Suzuki Y; Suetake S; Okubo T; Ishii T; Nakazato A; Okuyama S
    J Pharmacol Exp Ther; 2003 Feb; 304(2):818-26. PubMed ID: 12538838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral flavin-containing monooxygenase-mediated metabolism of antidepressants in brain: immunochemical properties and immunocytochemical localization.
    Bhamre S; Bhagwat SV; Shankar SK; Williams DE; Ravindranath V
    J Pharmacol Exp Ther; 1993 Oct; 267(1):555-9. PubMed ID: 8229786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.